Spain authorises Phase III trial of Johnson & Johnson COVID-19 vaccine


  • World
  • Wednesday, 18 Nov 2020

FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration

MADRID (Reuters) - Spain's medicines agency authorised the launch of late-stage trials of Johnson & Johnson's COVID-19 vaccine on Wednesday as the race to develop successful vaccines intensifies.

The Phase III trial of the two-dose vaccination will be carried out in nine hospitals throughout Spain on volunteers both with and without previous health conditions, the AEMPS agency said in a statement.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Storm Bert causes power outages, disrupts travel in UK and Ireland
At least 18 dead in retaliatory sectarian attacks in Pakistan
Modi's BJP, allies to win election rebound in India's richest state, Maharashtra
NATO boss Rutte held talks with Trump in Florida, alliance says
Turkey replaces pro-Kurdish mayors with state officials in two eastern cities
Cyprus says Moody's A3 upgrade vote of confidence in economy
Indonesia agrees to transfer remaining Bali Nine to Australia
Australian police arrest three at climate protest at coal port
Wealthy countries back raising COP29 climate deal to $300 billion, sources say
Philippine VP says she would have Marcos assassinated if she were killed

Others Also Read